Clearside Biomedical, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €89.81M +325.5% €29.92M -396.5% 33.3% +0.81 pp N/A N/A
    (estimated) €21.11M +135.0% -€10.09M +48.7% -47.8% +0.28 pp N/A N/A
    (estimated) €8.98M +205.2% -€6.79M -67.9% -75.5% +6.4 pp N/A N/A
    (estimated) €2.94M +25.2% -€21.18M -1.3% -719.5% +1.9 pp N/A N/A
    (estimated) €2.35M +64.7% -€21.46M -27.2% -912.8% +12 pp N/A N/A
    €1.43M -79.8% -€29.47M +5.7% -2,064.4% -17 pp -€20.35M +45.0% -1,425.5% -12 pp
    €7.06M +519.9% -€27.87M -4.7% -394.9% +22 pp -€14.04M +24.7% -198.9% +7.9 pp
    €1.14M -95.5% -€29.23M -9,161.5% -2,567.5% -26 pp -€11.26M +22.2% -988.6% -9.5 pp
    €25.38M +274.7% €322.61K -102.1% 1.3% +2.3 pp -€9.21M -17.8% -36.3% +1.3 pp
    €6.77M +263.3% -€15.47M -41.0% -228.4% +12 pp -€11.21M -51.7% -165.5% +11 pp
    €1.86M +7,143.3% -€26.22M -63.1% -1,406.3% +2.7K pp -€23.20M -65.8% -1,244.5% +2.6K pp
    €25.74K -91.3% -€71.06M +40.4% -276,060.0% -2.6K pp -€67.88M +55.8% -263,706.7% -2.5K pp
    €296.01K -33.7% -€50.60M +127.9% -17,094.2% -120 pp -€43.57M +123.6% -14,718.0% -100 pp
    €446.16K +∞% -€22.21M +46.7% -4,977.3% -50 pp -€19.48M +63.7% -4,366.5% -44 pp
    €0.00 +NaN% -€15.13M +73.1% N/A -€11.90M +54.4% N/A
    €0.00 +NaN% -€8.74M +40.5% N/A -€7.71M +32.6% N/A
    €0.00 +NaN% -€6.22M +84.5% N/A -€5.81M +117.2% N/A
    €0.00 -€3.37M N/A -€2.68M N/A

    Notifications